Literature DB >> 9894728

Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation.

M Sato1, T Matsushima, S Takada, N Hatsumi, K Kim, M Sakuraya, T Saito, J Tamura, M Karasawa, H Murakami, T Naruse.   

Abstract

We report a case of haemophagocytic syndrome (HPS) occurring after allogeneic bone marrow transplantation (BMT) for acute promyelocytic leukaemia (APL) in a patient in fourth complete remission (CR). Anti-cytomegalovirus (CMV) antibody (Ab) was negative in this patient before BMT. BMT was performed from an HLA-identical unrelated donor who was positive for CMV Ab. After bone marrow engraftment and haematological recovery, severe acute graft-versus-host disease (GVHD) developed. This patient was treated with methylprednisolone in addition to cyclosporin A (CsA). Acute GVHD showed partial improvement, but CMV antigenaemia was observed. Despite administration of gancyclovir and immunoglobulin, CMV antigenaemia showed no improvement and HPS developed. As no other infections or malignancies were observed, we suspect that CMV infection was the trigger for development of HPS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9894728     DOI: 10.1038/sj.bmt.1701501

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

Review 1.  Graft failure due to hemophagocytic syndrome after autologous peripheral blood stem cell transplantation.

Authors:  K Fukuno; H Tsurumi; T Yamada; M Oyama; H Moriwaki
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

2.  Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation.

Authors:  Maho Koyama; Akihisa Sawada; Masahiro Yasui; Masami Inoue; Keisei Kawa
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

3.  Evidence for cytomegalovirus-induced haemophagocytic syndrome in a young patient with AIDS.

Authors:  Kosuke Ohkuma; Takeshi Saraya; Mitsuru Sada; Shin Kawai
Journal:  BMJ Case Rep       Date:  2013-09-25

4.  Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT.

Authors:  R Kobayashi; J Tanaka; S Hashino; S Ota; Y Torimoto; Y Kakinoki; S Yamamoto; M Kurosawa; N Hatakeyama; Y Haseyama; H Sakai; K Sato; T Fukuhara
Journal:  Bone Marrow Transplant       Date:  2013-09-16       Impact factor: 5.483

5.  Hemophagocytic syndrome after hematopoietic stem cell transplantation: a prospective observational study.

Authors:  Abderrahman Abdelkefi; Wassim Ben Jamil; Lamia Torjman; Saloua Ladeb; Habib Ksouri; Amel Lakhal; Assia Ben Hassen; Abdeladhim Ben Abdeladhim; Tarek Ben Othman
Journal:  Int J Hematol       Date:  2009-02-28       Impact factor: 2.490

6.  Concomitant Hemophagocytic Lymphohistiocytosis and Cytomegalovirus Disease: A Case Based Systemic Review.

Authors:  Linn Åsholt Rolsdorph; Knut Anders Mosevoll; Lars Helgeland; Håkon Reikvam
Journal:  Front Med (Lausanne)       Date:  2022-04-19

Review 7.  Viral infections associated with haemophagocytic syndrome.

Authors:  Nadine Rouphael Maakaroun; Abeer Moanna; Jesse T Jacob; Helmut Albrecht
Journal:  Rev Med Virol       Date:  2010-03       Impact factor: 6.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.